elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38633441-EB050B3E-ED61-49D8-9793-3B3F41C5AB31
Q38633441-EB050B3E-ED61-49D8-9793-3B3F41C5AB31
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38633441-EB050B3E-ED61-49D8-9793-3B3F41C5AB31
A safety evaluation of canakinumab for the treatment of systemic onset juvenile idiopathic arthritis.
P2860
Q38633441-EB050B3E-ED61-49D8-9793-3B3F41C5AB31
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38633441-EB050B3E-ED61-49D8-9793-3B3F41C5AB31
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7b7863cb1d239c42e756d7071292ef3efb7ab05a
P2860
A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.